- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Imaging firms hit by declining earnings
The medical imaging device segment was one of the worst performing sectors in the healthcare industry during the second quarter of 1998, with earnings dropping 14.5% despite a revenue increase of 6.8%, according to a report produced by KPMG’s Health
The medical imaging device segment was one of the worst performing sectors in the healthcare industry during the second quarter of 1998, with earnings dropping 14.5% despite a revenue increase of 6.8%, according to a report produced by KPMGs Health Care Transaction Services division and WDI Healthcare Markets Group. Only the durable medical equipment and monitoring devices segments posted lower results, with earnings for those sectors dropping 28.2% and 36.8%, respectively.
For imaging device companies, the quarter continues a reduced profitability trend that has plagued the sector in recent periods. In the first quarter of this year, earnings decreased 1.9% with a 10.5% increase in revenue, according to KPMG and WDI, which is based in Hilton Head, SC. Fourth-quarter earnings were down 15.2% despite a 9.6% increase in revenue.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
